Peri-implantitis Market
Report ID: SQMIG35A3581
Report ID: SQMIG35A3581
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3581 |
Region:
Global |
Published Date: May, 2026
Pages:
157
|Tables:
122
|Figures:
77
Global Peri-Implantitis Market size was valued at USD 1.70 Billion in 2024 and is poised to grow from USD 1.84 Billion in 2025 to USD 3.46 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).
The peri-implantitis market growth is mainly driven by the fast rate at which dental implants are being performed worldwide; this increase in patients who are at risk for peri-implantitis has created a greater demand for diagnostic and therapeutic solutions. Peri-implantitis is an inflammatory typically chronic infection of the soft and/or hard tissue surrounding a dental implant, which could eventually lead to bone loss and/or implant failure; due to the increase in cost and complexity of treatment for peri-implantitis, it is important to address this issue as early as possible.
The evolution of the peri-implantitis market trends over the last 30-40 years can be seen to have shifted from mechanical removal of biofilm (debridement) and systemic antibiotics, to primary prevention (prophylactic) through diagnosis (diagnostics) along with secondary prevention (prophylactic) through localized antimicrobial delivery (therapeutics), laser therapy (therapeutics), and regenerative biomaterials (therapeutics). In addition, the growth of implant and clinical research linking early diagnosis with improved clinical outcomes are influencing the growth of the peri-implantitis market; the earlier an implant-related peri-implantitis condition is diagnosed the less likely complex surgery will be required therefore lowering the costs to manage the disease.
There are several investors and manufacturers who are now prioritizing the development of point-of-care diagnostic systems, minimally invasive decontamination systems, and regenerative biomaterials that enable patient treatment at chairside thus facilitating faster healing times. This is evident because clinics that are using point-of-care diagnostics, minimally invasive decontamination systems (manual and/or mechanical), and regenerative biomaterials are experiencing significantly fewer failures of implant therapy and thus their patients are expressing a greater level of satisfaction. In many cases, the combination of increased awareness of reimbursement and the increased number of dental implants being placed among the geriatric population and/or developing regions will continue to drive the growth of the peri-implantitis market; as such, commercializing affordable diagnostic and scalable training solutions will provide additional and specific opportunities to continue to grow the peri-implantitis market.
How is AI Improving Diagnosis and Treatment Planning in the Peri-Implantitis Market?
Artificial intelligence assists with diagnosing and planning treatment for peri-implantitis by permitting earlier detection of the condition and mapping objectively the lesions. It also allows for risk stratification to be established in a patient-specific manner and to produce a consistent treatment proposal for each patient that is seen in the per- implantitis marketplace. AI, through machine learning, uses radiographs and 3D images to identify signs of bone loss and patterns of infection around implanted teeth, determine which type of regenerative procedure to perform or whether to perform a non-surgical intervention, and create a longitudinal clinical database available for all practitioners involved in the patient's care. Overall, these features will allow for a shift from reactive to proactive care and standardization of decision-making across practice locations, as well as better communication between provider and patient. Deployments around the world show the value that AI provides through supporting routine monitoring and providing a streamlined workflow so that clinicians can concentrate on treating their patients and obtaining positive outcomes.
Millennium Dental Technologies is set to launch its LANAP AI Workflow by May 2025. This system includes both the PerioLase laser and a comprehensive isolation and automation tool to provide support for both LAPIP (Lasers for the Treatment of Peri-implantitis) and BLAST (Bone Loss Assessment System for Treatment of All Patients with Teeth and Implants). This new technology will reduce the amount of time that patients are in the dentist's chair, increase the precision of the surgical/procedural process, and increase the scale of advanced implant salvage techniques in order to achieve widespread market penetration and improved overall efficiency.
Market snapshot - (2026-2033)
Global Market Size
USD 1.7 Billion
Largest Segment
Surgical Treatment
Fastest Growth
Surgical Treatment
Growth Rate
8.2% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global peri-implantitis market is segmented by treatment type, product type, end user, distribution channel and region. Based on treatment type, the market is segmented into non-surgical treatment, surgical treatment and implant removal & replacement. Based on product type, the market is segmented into dental lasers, ultrasonic & mechanical debridement devices, air polishing devices, bone graft materials, barrier membranes, antimicrobial agents, implant cleaning & decontamination systems and others. Based on end user, the market is segmented into dental clinics, dental hospitals and academic & research institutes. Based on distribution channel, the market is segmented into direct sales, distributors & dealers and e-commerce/online procurement. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The implant cleaning and decontamination systems segment is the leading segment because these systems provide targeted biofilm removal and surface detoxification, which is critical to stopping tissue destruction around an implant. These systems offer a focused approach to treatment and are compatible with the materials used to create the implant, allowing clinicians to have predictable results and shorter treatment time. The substantial amount of clinical evidence supporting the effectiveness of implant cleaning and decontamination systems, as well as their integration with adjunctive devices, and the manufacturers' focus on creating specialized protocols, encourage purchasers who are focused on their practice to purchase and use implant cleaning and decontamination systems more frequently, which reinforces their critical importance in the care pathway for patients who have peri-implantitis.
However, antimicrobial agents are witnessing strongest growth as clinicians adopt localized pharmacologic adjuncts that streamline chairside care. Novel sustained-release formulations and targeted delivery enhance pathogen control and expand preventive and adjunctive indications, stimulating product development and opening opportunities for integrated treatment solutions that accelerate market expansion.
Dental clinics are now the leading segment of the dental implant market as they are seen as the primary location for regular care of dental implants and for the detection of early peri-implantitis, which leads to a demand for an effective treatment option. Clinics' emphasis on efficient processes and cost-effective treatments also results in clinics making purchasing decisions based primarily on products that can be easily integrated into their practice. Because clinics maintain close relationships with their patients and have high volumes of patients receiving treatment from them, clinics are able to easily implement new treatment protocols, creating dental clinics to be one of the most key channels that influence daily dental practice and product acceptance by clinicians.
However, academic & research institutes are growing fastest due to translational studies and device validation that attract industry collaboration. Their clinical evidence generation and specialist training accelerate regulatory acceptance and inform commercial strategies, producing validated innovations that expand clinician confidence and unlock broader market opportunities.
To get detailed segments analysis, Request a Free Sample Report
The mature medical system in North America consists of established clinical practices, strong research capabilities, and numerous specialized doctors, meaning that there are many doctors who are used to using novel diagnostic techniques and treatment methods for treating patients with problems related to implants. The close relationship that academic institutions have with industries continually leads to the development of new products that are clinically proven, which will continue to lead to greater innovation and commercialization due to the large number of suppliers in the market. Professional organizations have developed formalized ways for healthcare to improve through continuing medical education and standardization of care pathways. As a result, the large amount of private sector investment and consolidation of distribution networks allows for healthcare practitioners to consistently access equipment (instruments and materials) necessary for quality, comprehensive, and coordinated evidence-based care for patients with implant-related conditions.
Peri-implantitis market share in the United States benefits from an extensive network of specialist periodontal and implant practices, high clinician familiarity with advanced decontamination and regenerative techniques, and early commercial availability of novel devices. Strong private investment and a competitive supplier landscape support rapid product refinement, while leading academic centres contribute clinical evidence and training. Integrated care pathways and widespread patient awareness further underpin market depth and sophisticated treatment adoption across urban and regional practices.
Peri-implantitis market outlook in Canada is characterized by an organized clinical community, an increase in subspecialty practices in implant dentistry, as well as a focus on evidence based protocols. Public and private practice work in collaboration through associations that help standardize both diagnostic criteria and your treatment protocols. Procurement decisions are made based off of evidence such as clinical proof of use, and having suppliers that are stable allows for easy access to specialty instruments and/or biomaterials when needed. Ongoing continuing education and regional centers of excellence help create knowledge and improve practitioner competency; thus improving patient outcomes in the management of peri-implant disease.
Europe is experiencing rapid market expansion as a result of cohesive regulatory frameworks, active clinical networks, and elevated emphasis on integrating oral health within national healthcare strategies. Professional associations and research consortia facilitate rapid dissemination of consensus guidelines and best practices for peri-implant management, while domestic manufacturers invest in clinically validated technologies tailored to regional needs. Training programmes and specialist services are expanding, improving clinician capability to deliver complex restorative and regenerative treatments. Procurement and reimbursement evolution in several markets supports broader access, and rising patient engagement with implant dentistry drives demand for standardized, high quality care. These combined factors enable a more coordinated and scalable approach to peri-implant disease across diverse healthcare systems.
Peri-implantitis market forecast in Germany gains from a solid hospital base and private clinic network characterized by intense oral surgery / periodontics specialization. Close relationships between researchers and national companies assist in technology transfer and validation of clinical research. Reimbursement policies and clinical guidelines provide structure for treating patients; in addition, practitioner networks facilitate rapid spread of innovation based on procedure changes. High-quality restorative and regenerative products are driven by doctor preference for evidence-based solutions and comprehensive interdisciplinary approaches to care.
Peri-implantitis market regional outlook in the United Kingdom is marked by dynamic expansion across private and specialist sectors, supported by active professional education and innovation adoption. A strong culture of clinical audit and outcome reporting drives evidence informed decision making, while flexible procurement in private clinics enables rapid integration of novel devices and adjunctive therapies. Collaboration between academic centres and industry fosters clinical trials and practitioner training, helping to scale advanced treatment protocols and extend specialized services beyond metropolitan centres.
Peri-implantitis market regional forecast in France is set to grow due to ongoing investments in training and continued provision of local specialist centres focusing on conservative and regenerative approaches. The developing relationships between periodontal organisations and implantology groups have also led to the development of standardised diagnostic and treatment guidelines. Furthermore, the procurement trends are shifting towards the use of clinically validated technologies, and the increased levels of patient engagement are contributing to the demand for restorative rehabilitation. In addition, strengthening strategic partnerships between clinical research groups and suppliers has helped accelerate the local uptake of adjunctive therapies; enabling the provision of multidisciplinary management of patients exhibiting complex peri-implantitis disease.
Asia Pacific is strengthening its role by enhancing clinical capabilities, expanding domestic manufacturing capacity, and fostering strategic collaborations with global dental technology providers. Major urban centres are developing specialized clinics and training hubs that cultivate clinician expertise in contemporary diagnostics and minimally invasive interventions for peri-implant conditions. Regulatory modernization and targeted professional development initiatives facilitate the regional introduction of innovative devices and biomaterials. Local manufacturers are adapting products to regional practice preferences, while cross border research partnerships and clinical studies are elevating standards of evidence and care. These dynamics collectively support broader adoption of comprehensive peri-implant management across diverse healthcare environments.
Peri-implantitis market penetration in Japan is defined by a complex clinical system, with an emphasis on precision dentistry, as well as partnerships between research centres and manufacturers. Clinicians are highly skilled at using advanced diagnostic imaging and microsurgical techniques, while product developers create high-quality materials and procedural adjuncts. Continuing education and specialized fellowships allow practitioners to hone their skills so that they can evaluate new therapies and incorporate them into their standard operating procedures.
Peri-implantitis market analysis in South Korea is characterized by rapid clinical innovation, an active domestic dental device sector, and a strong focus on aesthetic and restorative excellence. Clinical practitioners are quick to evaluate and incorporate emerging decontamination technologies and biomaterials, supported by local manufacturers that adapt designs to practitioner feedback. Professional societies and training programmes facilitate dissemination of refined protocols, while collaborative initiatives with international partners enhance evidence generation and expand access to multidisciplinary peri-implant care.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Implant Adoption Rates
Advances In Treatment Modalities
Restraints
Limited Reimbursement Coverage
High Clinical Complexity Requirements
Request Free Customization of this report to help us to meet your business objectives.
The international peri-implantitis market's competitiveness is influenced by the implant manufacturers and other newer company acquisitions, and these are followed up by using exclusive distribution contracts; as well as innovations that use advanced technology to develop new products based on existing implants. To illustrate, Straumann purchased GalvoSurge in 2023 for an additional method of cleaning implants, and resources are being developed by new companies for use with antimicrobial coatings; however, the current focus is on using an electricity-based method of using heat to kill bacteria as an alternative to the use of systemic antibiotics and to create a less invasive treatment.
Top Player’s Company Profile
Recent Developments in the Peri-implantitis Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, a key driver is the rapid global expansion of dental implant procedures that increases the at-risk population and demand for diagnostics and therapeutics, while a second driver is continuous advances in treatment modalities including minimally invasive decontamination, localized antimicrobials and regenerative biomaterials. A major restraint remains limited reimbursement coverage which can delay patient uptake and slow adoption of advanced therapies. North America continues to dominate the market due to mature clinical infrastructure and strong research–industry linkages, and implant cleaning and decontamination systems lead the product landscape because they deliver targeted biofilm removal and predictable chairside outcomes.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.7 Billion |
| Market size value in 2033 | USD 3.46 Billion |
| Growth Rate | 8.2% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Peri-implantitis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Peri-implantitis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Peri-implantitis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Peri-implantitis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Peri-Implantitis Market size was valued at USD 1.7 Billion in 2024 and is poised to grow from USD 1.84 Billion in 2025 to USD 3.46 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).
Competitive intensity in the global peri-implantitis market is driven by implant OEMs and specialist startups pursuing M&A, exclusive distribution agreements and platform innovation. For example Straumann acquired GalvoSurge in 2023 to add an implant-cleaning system to its portfolio while startups advance antimicrobial coatings and non-contact induction heating to limit systemic antibiotics and support less invasive treatments. 'Straumann Group', 'Dentsply Sirona Inc.', 'Zimmer Biomet Holdings, Inc.', 'Institut Straumann AG', 'Neoss Group', 'Osstem Implant Co., Ltd.', 'MegaGen Implant Co., Ltd.', 'Nobel Biocare Services AG', 'BioHorizons, Inc.', 'Envista Holdings Corporation', 'ZimVie Inc.', 'Henry Schein, Inc.', 'Datum Dental Ltd.', 'Hu-Friedy Mfg. Co., LLC', 'Ivoclar Vivadent AG', 'Kuraray Noritake Dental Inc.', 'Young Innovations, Inc.', 'Coltene Holding AG', 'ACTEON Group', 'Fotona d.o.o.'
An increase in dental implant procedures expands the pool of patients requiring long term follow up and management, which directly elevates demand for peri-implantitis diagnostics, therapeutic interventions, and supportive maintenance services. As clinicians encounter a larger volume of implant cases, investment in specialized treatment options, regenerative materials, and antimicrobial therapies becomes more attractive, and dental practices adopt protocols for early detection and management. This cumulative clinical focus stimulates market activity across devices, consumables, and professional services related to peri-implant disease care. Stakeholders prioritize product development accordingly.
Minimally Invasive Therapies: Adoption of less invasive peri implantitis treatments, including targeted debridement, laser assisted decontamination and biomaterial based regenerative approaches, is reshaping clinical practice. These options emphasize preservation of surrounding tissues, reduced post procedural morbidity and faster patient recovery, increasing acceptance among clinicians and patients. As clinicians prioritize predictable, conservative interventions, demand grows for instruments, consumables and education, encouraging manufacturers to develop integrated solutions and partnerships to accelerate adoption and support long term implant retention.
Why does North America Dominate the Global Peri-implantitis Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
